Skip to main content

CapForce Inc.

CFOR
Exchange
OTC
Industry
Services-Medical Laboratories
SEC CIK
0001293818

No open-market purchases or sales by CapForce Inc. insiders were filed in the last 90 days; no institution reported holding it in 13F filings for Q2 2026; no superinvestor holds it.

Q1 2022 vs. Q4 2021

How the institutions holding CapForce Inc. changed between Q4 2021 and Q1 2022.

All holders in Q1 2022All holders in Q4 2021

13F holders of CFOR: Q4 2021 compared with Q1 2022
MeasureQ4 2021Q1 2022Change
Holders3128−3
Shares5.10M4.12M−982.6K (−19.3%)
Value$5.11M$3.08M−$2.02M (−39.6%)

New holders (3)

Institutions that held CapForce Inc. at the end of Q1 2022 but not at the end of Q4 2021.

Institutions new to CFOR in Q1 2022
InstitutionSharesValue% of portfolio
Gsa Capital Partners LLP97,810$73.0K0.01%
First Republic Investment Management, Inc.17,000$13.0K0.00%
HRT Financial LP15,760$11.0K0.00%

Sold out (6)

Institutions that held CapForce Inc. at the end of Q4 2021 and filed for Q1 2022 without it.

Institutions that sold out of CFOR in Q1 2022
InstitutionShares, Q4 2021Value, Q4 2021
Citadel Advisors LLC114,316$115.0K
Two Sigma Investments, LP106,332$106.0K
Dimensional Fund Advisors LP53,612$54.0K
Two Sigma Securities, LLC30,753$31.0K
Charles Schwab Investment Management Inc22,600$23.0K
Susquehanna International Group, LLP16,925$17.0K